Prestige Consumer Healthcare ROE 2010-2023 | PBH
Current and historical return on equity (ROE) values for Prestige Consumer Healthcare (PBH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Prestige Consumer Healthcare ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2023-12-31 | $-0.08B | $1.60B | -5.34% |
| 2023-09-30 | $-0.08B | $1.54B | -5.33% |
| 2023-06-30 | $-0.09B | $1.48B | -5.45% |
| 2023-03-31 | $-0.08B | $1.45B | -5.24% |
| 2022-12-31 | $0.21B | $1.69B | 12.98% |
| 2022-09-30 | $0.21B | $1.62B | 13.20% |
| 2022-06-30 | $0.20B | $1.59B | 13.15% |
| 2022-03-31 | $0.21B | $1.58B | 13.73% |
| 2021-12-31 | $0.19B | $1.52B | 13.14% |
| 2021-09-30 | $0.18B | $1.46B | 12.95% |
| 2021-06-30 | $0.18B | $1.42B | 13.40% |
| 2021-03-31 | $0.17B | $1.36B | 12.80% |
| 2020-12-31 | $0.17B | $1.32B | 13.36% |
| 2020-09-30 | $0.16B | $1.28B | 13.58% |
| 2020-06-30 | $0.15B | $1.23B | 13.03% |
| 2020-03-31 | $0.14B | $1.17B | 12.51% |
| 2019-12-31 | $-0.03B | $1.16B | -3.04% |
| 2019-09-30 | $-0.03B | $1.11B | -2.99% |
| 2019-06-30 | $-0.04B | $1.10B | -3.11% |
| 2019-03-31 | $-0.04B | $1.10B | -3.07% |
| 2018-12-31 | $0.06B | $1.23B | 5.29% |
| 2018-09-30 | $0.34B | $1.19B | 28.63% |
| 2018-06-30 | $0.34B | $1.16B | 30.53% |
| 2018-03-31 | $0.34B | $1.18B | 32.76% |
| 2017-12-31 | $0.39B | $1.22B | 41.21% |
| 2017-09-30 | $0.11B | $0.90B | 12.79% |
| 2017-06-30 | $0.11B | $0.86B | 13.39% |
| 2017-03-31 | $0.07B | $0.82B | 8.80% |
| 2016-12-31 | $0.07B | $0.80B | 9.42% |
| 2016-09-30 | $0.07B | $0.78B | 9.14% |
| 2016-06-30 | $0.07B | $0.74B | 9.42% |
| 2016-03-31 | $0.10B | $0.74B | 14.21% |
| 2015-12-31 | $0.11B | $0.72B | 16.31% |
| 2015-09-30 | $0.10B | $0.69B | 15.93% |
| 2015-06-30 | $0.09B | $0.66B | 13.95% |
| 2015-03-31 | $0.08B | $0.63B | 12.91% |
| 2014-12-31 | $0.07B | $0.61B | 11.90% |
| 2014-09-30 | $0.05B | $0.59B | 9.09% |
| 2014-06-30 | $0.07B | $0.59B | 12.35% |
| 2014-03-31 | $0.07B | $0.56B | 13.59% |
| 2013-12-31 | $0.08B | $0.54B | 14.74% |
| 2013-09-30 | $0.09B | $0.54B | 17.21% |
| 2013-06-30 | $0.07B | $0.50B | 15.15% |
| 2013-03-31 | $0.07B | $0.48B | 14.51% |
| 2012-12-31 | $0.05B | $0.46B | 10.72% |
| 2012-09-30 | $0.04B | $0.44B | 10.59% |
| 2012-06-30 | $0.04B | $0.42B | 9.42% |
| 2012-03-31 | $0.04B | $0.40B | 9.66% |
| 2011-12-31 | $0.04B | $0.40B | 11.48% |
| 2011-09-30 | $0.04B | $0.39B | 9.69% |
| 2011-06-30 | $0.03B | $0.38B | 9.41% |
| 2011-03-31 | $0.03B | $0.36B | 8.24% |
| 2010-12-31 | $0.03B | $0.36B | 7.56% |
| 2010-09-30 | $0.04B | $0.35B | 10.41% |
| 2010-06-30 | $0.03B | $0.34B | 10.41% |
| 2010-03-31 | $0.03B | $0.33B | 10.08% |
| 2009-12-31 | $-0.18B | $0.33B | -58.95% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.378B | $1.128B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.756B | 24.12 |
| Stryker (SYK) | United States | $127.849B | 31.70 |
| Medtronic (MDT) | Ireland | $105.004B | 14.86 |
| Boston Scientific (BSX) | United States | $99.704B | 33.15 |
| EssilorLuxottica (ESLOY) | France | $97.123B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.671B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.031B | 28.96 |
| ResMed (RMD) | United States | $25.568B | 25.56 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.922B | 16.05 |
| Terumo (TRUMY) | Japan | $24.880B | 35.14 |
| Baxter (BAX) | United States | $20.069B | 14.64 |
| Koninklijke Philips (PHG) | Netherlands | $18.712B | 14.93 |
| Insulet (PODD) | United States | $11.642B | 61.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.457B | 0.00 |
| Demant (WILYY) | Denmark | $10.001B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.295B | 24.71 |
| BellRing Brands (BRBR) | United States | $7.115B | 38.25 |
| Haemonetics (HAE) | United States | $4.311B | 22.05 |
| Lantheus Holdings (LNTH) | United States | $4.215B | 10.88 |
| Perrigo (PRGO) | Ireland | $4.071B | 11.64 |
| GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
| Envista Holdings (NVST) | United States | $3.367B | 12.80 |
| Green Thumb Industries (GTBIF) | United States | $2.758B | 87.40 |
| Neogen (NEOG) | United States | $2.630B | 25.29 |
| QuidelOrtho (QDEL) | United States | $2.589B | 9.40 |
| ICU Medical (ICUI) | United States | $2.336B | 17.43 |
| TG Therapeutics (TGTX) | United States | $2.134B | 691.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.943B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| Owens & Minor (OMI) | United States | $1.836B | 17.62 |
| Agios Pharmaceuticals (AGIO) | United States | $1.631B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.486B | 46.29 |
| InMode (INMD) | Israel | $1.465B | 7.59 |
| LeMaitre Vascular (LMAT) | United States | $1.415B | 46.70 |
| AdaptHealth (AHCO) | United States | $1.253B | 9.43 |
| Warby Parker (WRBY) | United States | $1.189B | 0.00 |
| AtriCure (ATRC) | United States | $1.134B | 0.00 |
| MacroGenics (MGNX) | United States | $1.007B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.757B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.687B | 14.83 |
| BioLife Solutions (BLFS) | United States | $0.686B | 0.00 |
| Evolus (EOLS) | United States | $0.674B | 0.00 |
| Jin Medical (ZJYL) | China | $0.631B | 0.00 |
| Quanterix (QTRX) | United States | $0.602B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.591B | 0.00 |
| Valneva SE (VALN) | France | $0.538B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.533B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.521B | 11.29 |
| PetIQ (PETQ) | United States | $0.469B | 17.50 |
| ZimVie (ZIMV) | United States | $0.417B | 25.55 |
| Biote (BTMD) | United States | $0.411B | 3.91 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.65 |
| Zynex (ZYXI) | United States | $0.388B | 44.70 |
| Surmodics (SRDX) | United States | $0.378B | 40.80 |
| Aurora Cannabis (ACB) | Canada | $0.316B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.303B | 30.08 |
| Cerus (CERS) | United States | $0.297B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.256B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.243B | 14.80 |
| Ayr Wellness (AYRWF) | United States | $0.210B | 0.00 |
| Omeros (OMER) | United States | $0.194B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.175B | 0.00 |
| Veru (VERU) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 21.93 |
| Eagleford Energy (GRUSF) | United States | $0.135B | 68.05 |
| InterCure (INCR) | Israel | $0.108B | 18.15 |
| Fonar (FONR) | United States | $0.105B | 8.98 |
| Allurion Technologies (ALUR) | United States | $0.104B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.104B | 0.00 |
| MariMed (MRMD) | United States | $0.101B | 0.00 |
| Safety Shot (SHOT) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.073B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.057B | 3.72 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.019B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.36 |
| ProSomnus (OSA) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |